Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Neurovascular Stent Retrievers Market by Product (Balloon Expanding Stents, Self-Expanding Stents), by Material (Metal, Polymer) and by End-Users (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A02404

Pages: NA

Charts: NA

Tables: NA

Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early diagnosis and treatment can prevent complications and permanent injuries. Neurovascular stent retrievers are used to restore the blood flow during the stroke.

Increase in geriatric population, rise in incidence of neurological & epidemic disorders, and launch of innovative products for neurovascular stent retrievers drive the market growth. However, stringent regulatory requirements delay product approvals limit the growth.

The market is segmented based on product, material, end users, and geography. By product, it is bifurcated into balloon expanding stents and self-expanding stents. By material, it is classified into metal and polymer. By end users, it is divided into hospitals, ambulatory surgical centers, and clinics. By geography, it is studied across North America, Europe, Asia Pacific, and LAMEA.

Key Benefits

  • Comprehensive analysis of factors that drive and restrict the growth of the global neurovascular stent retrievers market is provided.
  • The projections in the market are made by studying the current market trends and future market potential for the period in terms of value.
  • Extensive analysis by technology and application helps understand the various trends and prevailing opportunities in the respective market
  • Key market players within the global neurovascular stent retrievers market are profiled in the market and their strategies are analyzed thoroughly, which helps understand the competitive outlook of the global neurovascular stent retrievers market.
  • Comprehensive analysis of all regions are provided that determines the prevailing opportunities in these geographies.

 Key Market Segments

  • By Product
    • Balloon Expanding Stents
    • Self-Expanding Stents
  • By Material
    • Metal
      • Stainless Steel
      • Nitinol
    • Polymer
  • By End-Users
    • Hospitals
    • Ambulatory Surgical Centers
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Akron Inc.
  • Advent Devices Pvt. Ltd.
  • Nitinol Devices & Components, Inc.
  • Meril Life Science Pvt. Ltd.
  • Norman Noble
  • Medtronic Plc
  • Stryker
  • STI Laser Industries, Ltd.
  • Hobbs Medical IN
  • W. L. Gore & Associates, Inc.

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: NEUROVASCULAR STENT RETRIEVERS MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Balloon Expanding Stents

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Self-Expanding Stents

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: NEUROVASCULAR STENT RETRIEVERS MARKET, BY MATERIAL

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Material

    • 5.2. Metal

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

      • 5.2.4. Stainless Steel

        • 5.2.4.1. Market Size and Forecast

      • 5.2.4. Nitinol

        • 5.2.4.1. Market Size and Forecast

    • 5.3. Polymer

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: NEUROVASCULAR STENT RETRIEVERS MARKET, BY END-USERS

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End-users

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Ambulatory Surgical Centers

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Others

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: NEUROVASCULAR STENT RETRIEVERS MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product

      • 7.2.3. Market Size and Forecast, By Material

      • 7.2.4. Market Size and Forecast, By End-users

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Neurovascular Stent Retrievers Market

        • 7.2.6.1. Market Size and Forecast, By Product
        • 7.2.6.2. Market Size and Forecast, By Material
        • 7.2.6.3. Market Size and Forecast, By End-users

      • 7.2.7. Canada Neurovascular Stent Retrievers Market

        • 7.2.7.1. Market Size and Forecast, By Product
        • 7.2.7.2. Market Size and Forecast, By Material
        • 7.2.7.3. Market Size and Forecast, By End-users

      • 7.2.8. Mexico Neurovascular Stent Retrievers Market

        • 7.2.8.1. Market Size and Forecast, By Product
        • 7.2.8.2. Market Size and Forecast, By Material
        • 7.2.8.3. Market Size and Forecast, By End-users

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product

      • 7.3.3. Market Size and Forecast, By Material

      • 7.3.4. Market Size and Forecast, By End-users

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Neurovascular Stent Retrievers Market

        • 7.3.6.1. Market Size and Forecast, By Product
        • 7.3.6.2. Market Size and Forecast, By Material
        • 7.3.6.3. Market Size and Forecast, By End-users

      • 7.3.7. Germany Neurovascular Stent Retrievers Market

        • 7.3.7.1. Market Size and Forecast, By Product
        • 7.3.7.2. Market Size and Forecast, By Material
        • 7.3.7.3. Market Size and Forecast, By End-users

      • 7.3.8. Italy Neurovascular Stent Retrievers Market

        • 7.3.8.1. Market Size and Forecast, By Product
        • 7.3.8.2. Market Size and Forecast, By Material
        • 7.3.8.3. Market Size and Forecast, By End-users

      • 7.3.9. Spain Neurovascular Stent Retrievers Market

        • 7.3.9.1. Market Size and Forecast, By Product
        • 7.3.9.2. Market Size and Forecast, By Material
        • 7.3.9.3. Market Size and Forecast, By End-users

      • 7.3.10. UK Neurovascular Stent Retrievers Market

        • 7.3.10.1. Market Size and Forecast, By Product
        • 7.3.10.2. Market Size and Forecast, By Material
        • 7.3.10.3. Market Size and Forecast, By End-users

      • 7.3.11. Russia Neurovascular Stent Retrievers Market

        • 7.3.11.1. Market Size and Forecast, By Product
        • 7.3.11.2. Market Size and Forecast, By Material
        • 7.3.11.3. Market Size and Forecast, By End-users

      • 7.3.12. Rest Of Europe Neurovascular Stent Retrievers Market

        • 7.3.12.1. Market Size and Forecast, By Product
        • 7.3.12.2. Market Size and Forecast, By Material
        • 7.3.12.3. Market Size and Forecast, By End-users

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product

      • 7.4.3. Market Size and Forecast, By Material

      • 7.4.4. Market Size and Forecast, By End-users

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Neurovascular Stent Retrievers Market

        • 7.4.6.1. Market Size and Forecast, By Product
        • 7.4.6.2. Market Size and Forecast, By Material
        • 7.4.6.3. Market Size and Forecast, By End-users

      • 7.4.7. Japan Neurovascular Stent Retrievers Market

        • 7.4.7.1. Market Size and Forecast, By Product
        • 7.4.7.2. Market Size and Forecast, By Material
        • 7.4.7.3. Market Size and Forecast, By End-users

      • 7.4.8. India Neurovascular Stent Retrievers Market

        • 7.4.8.1. Market Size and Forecast, By Product
        • 7.4.8.2. Market Size and Forecast, By Material
        • 7.4.8.3. Market Size and Forecast, By End-users

      • 7.4.9. South Korea Neurovascular Stent Retrievers Market

        • 7.4.9.1. Market Size and Forecast, By Product
        • 7.4.9.2. Market Size and Forecast, By Material
        • 7.4.9.3. Market Size and Forecast, By End-users

      • 7.4.10. Australia Neurovascular Stent Retrievers Market

        • 7.4.10.1. Market Size and Forecast, By Product
        • 7.4.10.2. Market Size and Forecast, By Material
        • 7.4.10.3. Market Size and Forecast, By End-users

      • 7.4.11. Thailand Neurovascular Stent Retrievers Market

        • 7.4.11.1. Market Size and Forecast, By Product
        • 7.4.11.2. Market Size and Forecast, By Material
        • 7.4.11.3. Market Size and Forecast, By End-users

      • 7.4.12. Malaysia Neurovascular Stent Retrievers Market

        • 7.4.12.1. Market Size and Forecast, By Product
        • 7.4.12.2. Market Size and Forecast, By Material
        • 7.4.12.3. Market Size and Forecast, By End-users

      • 7.4.13. Indonesia Neurovascular Stent Retrievers Market

        • 7.4.13.1. Market Size and Forecast, By Product
        • 7.4.13.2. Market Size and Forecast, By Material
        • 7.4.13.3. Market Size and Forecast, By End-users

      • 7.4.14. Rest of Asia Pacific Neurovascular Stent Retrievers Market

        • 7.4.14.1. Market Size and Forecast, By Product
        • 7.4.14.2. Market Size and Forecast, By Material
        • 7.4.14.3. Market Size and Forecast, By End-users

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product

      • 7.5.3. Market Size and Forecast, By Material

      • 7.5.4. Market Size and Forecast, By End-users

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Neurovascular Stent Retrievers Market

        • 7.5.6.1. Market Size and Forecast, By Product
        • 7.5.6.2. Market Size and Forecast, By Material
        • 7.5.6.3. Market Size and Forecast, By End-users

      • 7.5.7. South Africa Neurovascular Stent Retrievers Market

        • 7.5.7.1. Market Size and Forecast, By Product
        • 7.5.7.2. Market Size and Forecast, By Material
        • 7.5.7.3. Market Size and Forecast, By End-users

      • 7.5.8. Saudi Arabia Neurovascular Stent Retrievers Market

        • 7.5.8.1. Market Size and Forecast, By Product
        • 7.5.8.2. Market Size and Forecast, By Material
        • 7.5.8.3. Market Size and Forecast, By End-users

      • 7.5.9. UAE Neurovascular Stent Retrievers Market

        • 7.5.9.1. Market Size and Forecast, By Product
        • 7.5.9.2. Market Size and Forecast, By Material
        • 7.5.9.3. Market Size and Forecast, By End-users

      • 7.5.10. Argentina Neurovascular Stent Retrievers Market

        • 7.5.10.1. Market Size and Forecast, By Product
        • 7.5.10.2. Market Size and Forecast, By Material
        • 7.5.10.3. Market Size and Forecast, By End-users

      • 7.5.11. Rest of LAMEA Neurovascular Stent Retrievers Market

        • 7.5.11.1. Market Size and Forecast, By Product
        • 7.5.11.2. Market Size and Forecast, By Material
        • 7.5.11.3. Market Size and Forecast, By End-users

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Nitinol Devices And Components, Inc.

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Stryker

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Medtronic Plc

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Norman Noble

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. STI Laser Industries, Ltd.

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Hobbs Medical IN

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Akron Inc.

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Advent Devices Pvt. Ltd.

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Meril Life Science Pvt. Ltd.

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. W. L. Gore And Associates, Inc.

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL NEUROVASCULAR STENT RETRIEVERS MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL NEUROVASCULAR STENT RETRIEVERS MARKET FOR BALLOON EXPANDING STENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL NEUROVASCULAR STENT RETRIEVERS MARKET FOR SELF-EXPANDING STENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL NEUROVASCULAR STENT RETRIEVERS MARKET, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL NEUROVASCULAR STENT RETRIEVERS MARKET FOR METAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL NEUROVASCULAR STENT RETRIEVERS MARKET FOR POLYMER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL NEUROVASCULAR STENT RETRIEVERS MARKET, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL NEUROVASCULAR STENT RETRIEVERS MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL NEUROVASCULAR STENT RETRIEVERS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL NEUROVASCULAR STENT RETRIEVERS MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL NEUROVASCULAR STENT RETRIEVERS MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. NORTH AMERICA NEUROVASCULAR STENT RETRIEVERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. NORTH AMERICA NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 14. NORTH AMERICA NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 15. NORTH AMERICA NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 16. U.S. NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 17. U.S. NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 18. U.S. NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 19. CANADA NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 20. CANADA NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 21. CANADA NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 22. MEXICO NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 23. MEXICO NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 24. MEXICO NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 25. EUROPE NEUROVASCULAR STENT RETRIEVERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 26. EUROPE NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 27. EUROPE NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 28. EUROPE NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 29. FRANCE NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 30. FRANCE NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 31. FRANCE NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 32. GERMANY NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 33. GERMANY NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 34. GERMANY NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 35. ITALY NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 36. ITALY NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 37. ITALY NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 38. SPAIN NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 39. SPAIN NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 40. SPAIN NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 41. UK NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 42. UK NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 43. UK NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 44. RUSSIA NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 45. RUSSIA NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 46. RUSSIA NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 47. REST OF EUROPE NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 48. REST OF EUROPE NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 49. REST OF EUROPE NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 50. ASIA-PACIFIC NEUROVASCULAR STENT RETRIEVERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 51. ASIA-PACIFIC NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 52. ASIA-PACIFIC NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 53. ASIA-PACIFIC NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 54. CHINA NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 55. CHINA NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 56. CHINA NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 57. JAPAN NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 58. JAPAN NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 59. JAPAN NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 60. INDIA NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 61. INDIA NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 62. INDIA NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 63. SOUTH KOREA NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 64. SOUTH KOREA NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 65. SOUTH KOREA NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 66. AUSTRALIA NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 67. AUSTRALIA NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 68. AUSTRALIA NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 69. THAILAND NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 70. THAILAND NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 71. THAILAND NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 72. MALAYSIA NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 73. MALAYSIA NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 74. MALAYSIA NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 75. INDONESIA NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 76. INDONESIA NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 77. INDONESIA NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 78. REST OF ASIA PACIFIC NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 79. REST OF ASIA PACIFIC NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 80. REST OF ASIA PACIFIC NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 81. LAMEA NEUROVASCULAR STENT RETRIEVERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 82. LAMEA NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 83. LAMEA NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 84. LAMEA NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 85. BRAZIL NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 86. BRAZIL NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 87. BRAZIL NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 88. SOUTH AFRICA NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 89. SOUTH AFRICA NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 90. SOUTH AFRICA NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 91. SAUDI ARABIA NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 92. SAUDI ARABIA NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 93. SAUDI ARABIA NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 94. UAE NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 95. UAE NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 96. UAE NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 97. ARGENTINA NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 98. ARGENTINA NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 99. ARGENTINA NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 100. REST OF LAMEA NEUROVASCULAR STENT RETRIEVERS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 101. REST OF LAMEA NEUROVASCULAR STENT RETRIEVERS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 102. REST OF LAMEA NEUROVASCULAR STENT RETRIEVERS, BY END-USERS, 2025-2033 ($MILLION)
  • TABLE 103. NITINOL DEVICES AND COMPONENTS, INC.: KEY EXECUTIVES
  • TABLE 104. NITINOL DEVICES AND COMPONENTS, INC.: COMPANY SNAPSHOT
  • TABLE 105. NITINOL DEVICES AND COMPONENTS, INC.: OPERATING SEGMENTS
  • TABLE 106. NITINOL DEVICES AND COMPONENTS, INC.: PRODUCT PORTFOLIO
  • TABLE 107. NITINOL DEVICES AND COMPONENTS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 108. STRYKER: KEY EXECUTIVES
  • TABLE 109. STRYKER: COMPANY SNAPSHOT
  • TABLE 110. STRYKER: OPERATING SEGMENTS
  • TABLE 111. STRYKER: PRODUCT PORTFOLIO
  • TABLE 112. STRYKER: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 114. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 115. MEDTRONIC PLC: OPERATING SEGMENTS
  • TABLE 116. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 117. MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. NORMAN NOBLE: KEY EXECUTIVES
  • TABLE 119. NORMAN NOBLE: COMPANY SNAPSHOT
  • TABLE 120. NORMAN NOBLE: OPERATING SEGMENTS
  • TABLE 121. NORMAN NOBLE: PRODUCT PORTFOLIO
  • TABLE 122. NORMAN NOBLE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 123. STI LASER INDUSTRIES, LTD.: KEY EXECUTIVES
  • TABLE 124. STI LASER INDUSTRIES, LTD.: COMPANY SNAPSHOT
  • TABLE 125. STI LASER INDUSTRIES, LTD.: OPERATING SEGMENTS
  • TABLE 126. STI LASER INDUSTRIES, LTD.: PRODUCT PORTFOLIO
  • TABLE 127. STI LASER INDUSTRIES, LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 128. HOBBS MEDICAL IN: KEY EXECUTIVES
  • TABLE 129. HOBBS MEDICAL IN: COMPANY SNAPSHOT
  • TABLE 130. HOBBS MEDICAL IN: OPERATING SEGMENTS
  • TABLE 131. HOBBS MEDICAL IN: PRODUCT PORTFOLIO
  • TABLE 132. HOBBS MEDICAL IN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 133. AKRON INC.: KEY EXECUTIVES
  • TABLE 134. AKRON INC.: COMPANY SNAPSHOT
  • TABLE 135. AKRON INC.: OPERATING SEGMENTS
  • TABLE 136. AKRON INC.: PRODUCT PORTFOLIO
  • TABLE 137. AKRON INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 138. ADVENT DEVICES PVT. LTD.: KEY EXECUTIVES
  • TABLE 139. ADVENT DEVICES PVT. LTD.: COMPANY SNAPSHOT
  • TABLE 140. ADVENT DEVICES PVT. LTD.: OPERATING SEGMENTS
  • TABLE 141. ADVENT DEVICES PVT. LTD.: PRODUCT PORTFOLIO
  • TABLE 142. ADVENT DEVICES PVT. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 143. MERIL LIFE SCIENCE PVT. LTD.: KEY EXECUTIVES
  • TABLE 144. MERIL LIFE SCIENCE PVT. LTD.: COMPANY SNAPSHOT
  • TABLE 145. MERIL LIFE SCIENCE PVT. LTD.: OPERATING SEGMENTS
  • TABLE 146. MERIL LIFE SCIENCE PVT. LTD.: PRODUCT PORTFOLIO
  • TABLE 147. MERIL LIFE SCIENCE PVT. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 148. W. L. GORE AND ASSOCIATES, INC.: KEY EXECUTIVES
  • TABLE 149. W. L. GORE AND ASSOCIATES, INC.: COMPANY SNAPSHOT
  • TABLE 150. W. L. GORE AND ASSOCIATES, INC.: OPERATING SEGMENTS
  • TABLE 151. W. L. GORE AND ASSOCIATES, INC.: PRODUCT PORTFOLIO
  • TABLE 152. W. L. GORE AND ASSOCIATES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROVASCULAR STENT RETRIEVERS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL NEUROVASCULAR STENT RETRIEVERS MARKET
  • FIGURE 3. SEGMENTATION NEUROVASCULAR STENT RETRIEVERS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN NEUROVASCULAR STENT RETRIEVERS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALNEUROVASCULAR STENT RETRIEVERS MARKET
  • FIGURE 11. NEUROVASCULAR STENT RETRIEVERS MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. NEUROVASCULAR STENT RETRIEVERS MARKET FOR BALLOON EXPANDING STENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. NEUROVASCULAR STENT RETRIEVERS MARKET FOR SELF-EXPANDING STENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. NEUROVASCULAR STENT RETRIEVERS MARKET SEGMENTATION, BY BY MATERIAL
  • FIGURE 15. NEUROVASCULAR STENT RETRIEVERS MARKET FOR METAL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. NEUROVASCULAR STENT RETRIEVERS MARKET FOR POLYMER, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. NEUROVASCULAR STENT RETRIEVERS MARKET SEGMENTATION, BY BY END-USERS
  • FIGURE 18. NEUROVASCULAR STENT RETRIEVERS MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. NEUROVASCULAR STENT RETRIEVERS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. NEUROVASCULAR STENT RETRIEVERS MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 25. COMPETITIVE DASHBOARD
  • FIGURE 26. COMPETITIVE HEATMAP: NEUROVASCULAR STENT RETRIEVERS MARKET
  • FIGURE 27. TOP PLAYER POSITIONING, 2024
  • FIGURE 28. NITINOL DEVICES AND COMPONENTS, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 29. NITINOL DEVICES AND COMPONENTS, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 30. NITINOL DEVICES AND COMPONENTS, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 31. STRYKER: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 32. STRYKER: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 33. STRYKER: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 34. MEDTRONIC PLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 35. MEDTRONIC PLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 36. MEDTRONIC PLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 37. NORMAN NOBLE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. NORMAN NOBLE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. NORMAN NOBLE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. STI LASER INDUSTRIES, LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. STI LASER INDUSTRIES, LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. STI LASER INDUSTRIES, LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. HOBBS MEDICAL IN: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. HOBBS MEDICAL IN: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. HOBBS MEDICAL IN: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. AKRON INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. AKRON INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. AKRON INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. ADVENT DEVICES PVT. LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. ADVENT DEVICES PVT. LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. ADVENT DEVICES PVT. LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. MERIL LIFE SCIENCE PVT. LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. MERIL LIFE SCIENCE PVT. LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. MERIL LIFE SCIENCE PVT. LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 55. W. L. GORE AND ASSOCIATES, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 56. W. L. GORE AND ASSOCIATES, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 57. W. L. GORE AND ASSOCIATES, INC.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Neurovascular Stent Retrievers Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved